Literature DB >> 24016071

CellMinerHCC: a microarray-based expression database for hepatocellular carcinoma cell lines.

Frank Staib1, Markus Krupp, Thorsten Maass, Timo Itzel, Arndt Weinmann, Ju-Seog Lee, Bertil Schmidt, Martina Müller, Snorri S Thorgeirsson, Peter R Galle, Andreas Teufel.   

Abstract

BACKGROUND & AIMS: Therapeutic options for hepatocellular carcinoma (HCC) still remain limited. Development of gene targeted therapies is a promising option. A better understanding of the underlying molecular biology is gained in in vitro experiments. However, even with targeted manipulation of gene expression varying treatment responses were observed in diverse HCC cell lines. Therefore, information on gene expression profiles of various HCC cell lines may be crucial to experimental designs. To generate a publicly available database containing microarray expression profiles of diverse HCC cell lines.
METHODS: Microarray data were analyzed using an individually scripted R program package. Data were stored in a PostgreSQL database with a PHP written web interface. Evaluation and comparison of individual cell line expression profiles are supported via public web interface.
RESULTS: This database allows evaluation of gene expression profiles of 18 HCC cell lines and comparison of differential gene expression between multiple cell lines. Analysis of commonly regulated genes for signaling pathway enrichment and interactions demonstrates a liver tumor phenotype with enrichment of major cancer related KEGG signatures like 'cancer' and 'inflammatory response'. Further molecular associations of strong scientific interest, e.g. 'lipid metabolism', were also identified.
CONCLUSIONS: We have generated CellMinerHCC (http://www.medicalgenomics.org/cellminerhcc), a publicly available database containing gene expression data of 18 HCC cell lines. This database will aid in the design of in vitro experiments in HCC research, because the genetic specificities of various HCC cell lines will be considered.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HCC; bioinformatics; liver cancer; oncogenomics; systems biology

Mesh:

Year:  2013        PMID: 24016071      PMCID: PMC6993137          DOI: 10.1111/liv.12292

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  36 in total

1.  Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma.

Authors:  Hyun Goo Woo; Xin Wei Wang; Anuradha Budhu; Yun Hee Kim; So Mee Kwon; Zhao-You Tang; Zongtang Sun; Curtis C Harris; Snorri S Thorgeirsson
Journal:  Gastroenterology       Date:  2010-11-19       Impact factor: 22.682

Review 2.  Immunotherapy targeting colon cancer stem cells.

Authors:  Flora Iovino; Serena Meraviglia; Marisa Spina; Valentina Orlando; Vitanna Saladino; Francesco Dieli; Giorgio Stassi; Matilde Todaro
Journal:  Immunotherapy       Date:  2011-01       Impact factor: 4.196

3.  Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

Authors:  Anuradha Budhu; Marshonna Forgues; Qing-Hai Ye; Hu-Liang Jia; Ping He; Krista A Zanetti; Udai S Kammula; Yidong Chen; Lun-Xiu Qin; Zhao-You Tang; Xin Wei Wang
Journal:  Cancer Cell       Date:  2006-08       Impact factor: 31.743

Review 4.  Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

Authors:  Pia Vihinen; Veli-Matti Kähäri
Journal:  Int J Cancer       Date:  2002-05-10       Impact factor: 7.396

Review 5.  Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.

Authors:  Aaron J Schetter; Niels H H Heegaard; Curtis C Harris
Journal:  Carcinogenesis       Date:  2009-12-02       Impact factor: 4.944

6.  Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

Authors:  Ju-Seog Lee; In-Sun Chu; Jeonghoon Heo; Diego F Calvisi; Zongtang Sun; Tania Roskams; Anne Durnez; Anthony J Demetris; Snorri S Thorgeirsson
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

Review 7.  HCV-related hepatocellular carcinoma: From chronic inflammation to cancer.

Authors:  Giuseppe Castello; Stefania Scala; Giuseppe Palmieri; Steven A Curley; Francesco Izzo
Journal:  Clin Immunol       Date:  2009-11-11       Impact factor: 3.969

8.  Genetic signatures shared in embryonic liver development and liver cancer define prognostically relevant subgroups in HCC.

Authors:  Diana Becker; Ioannis Sfakianakis; Markus Krupp; Frank Staib; Aslihan Gerhold-Ay; Anja Victor; Harald Binder; Maria Blettner; Thorsten Maass; Snorri Thorgeirsson; Peter R Galle; Andreas Teufel
Journal:  Mol Cancer       Date:  2012-08-14       Impact factor: 27.401

9.  GENT: gene expression database of normal and tumor tissues.

Authors:  Gwangsik Shin; Tae-Wook Kang; Sungjin Yang; Su-Jin Baek; Yong-Su Jeong; Seon-Young Kim
Journal:  Cancer Inform       Date:  2011-05-09

10.  Mendelian Inheritance in Man and its online version, OMIM.

Authors:  Victor A McKusick
Journal:  Am J Hum Genet       Date:  2007-03-08       Impact factor: 11.025

View more
  7 in total

1.  Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice.

Authors:  Hadley J Hartwell; Keiko Y Petrosky; James G Fox; Nelson D Horseman; Arlin B Rogers
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

Review 2.  Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma.

Authors:  De-Leung Gu; Yen-Hsieh Chen; Jou-Ho Shih; Chi-Hung Lin; Yuh-Shan Jou; Chian-Feng Chen
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

3.  Systematic Analysis of Quantitative Logic Model Ensembles Predicts Drug Combination Effects on Cell Signaling Networks.

Authors:  M K Morris; D C Clarke; L C Osimiri; D A Lauffenburger
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-08-27

4.  The short isoform of PRLR suppresses the pentose phosphate pathway and nucleotide synthesis through the NEK9-Hippo axis in pancreatic cancer.

Authors:  Huizhen Nie; Pei-Qi Huang; Shu-Heng Jiang; Qin Yang; Li-Peng Hu; Xiao-Mei Yang; Jun Li; Ya-Hui Wang; Qing Li; Yi-Fan Zhang; Lei Zhu; Yan-Li Zhang; Yanqiu Yu; Gary Guishan Xiao; Yong-Wei Sun; Jianguang Ji; Zhi-Gang Zhang
Journal:  Theranostics       Date:  2021-02-06       Impact factor: 11.556

5.  Multi-color RGB marking enables clonality assessment of liver tumors in a murine xenograft model.

Authors:  Daniel Benten; Boris Fehse; Michael Thomaschewski; Kristoffer Riecken; Ludmilla Unrau; Tassilo Volz; Kerstin Cornils; Harald Ittrich; Denise Heim; Henning Wege; Ercan Akgün; Marc Lütgehetmann; Jan Dieckhoff; Michael Köpke; Maura Dandri
Journal:  Oncotarget       Date:  2017-12-14

6.  KM-express: an integrated online patient survival and gene expression analysis tool for the identification and functional characterization of prognostic markers in breast and prostate cancers.

Authors:  Xin Chen; Zhengqiang Miao; Mayur Divate; Zuxianglan Zhao; Edwin Cheung
Journal:  Database (Oxford)       Date:  2018-01-01       Impact factor: 3.451

7.  A validated, transitional and translational porcine model of hepatocellular carcinoma.

Authors:  Kyle M Schachtschneider; Regina M Schwind; Kwame A Darfour-Oduro; Arun K De; Lauretta A Rund; Kuldeep Singh; Daniel R Principe; Grace Guzman; Charles E Ray; Howard Ozer; Ron C Gaba; Lawrence B Schook
Journal:  Oncotarget       Date:  2017-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.